KYMERA THERAPEUTICS, INC. (KYMR) Shareholders’ equity 2019–2025
KYMERA THERAPEUTICS, INC. (KYMR) shareholders’ equity at each fiscal year-end, per SEC filings.
$1.6BFY2025 · since FY2019: -$74.4M → $1.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.6B | +89.0% |
| FY2024 | $835.6M | +111.6% |
| FY2023 | $395.0M | -19.4% |
| FY2022 | $490.2M | +6.6% |
| FY2021 | $459.6M | +61.9% |
| FY2020 | $283.9M | +481.5% |
| FY2019 | -$74.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice